Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307

BACKGROUND: Adjuvant bisphosphonates, when given in a low-estrogen environment, can decrease breast cancer recurrence and death. Treatment guidelines include recommendations for adjuvant bisphosphonates in postmenopausal patients. SWOG/Alliance/Canadian Cancer Trials Group/ECOG-ACRIN/NRG Oncology st...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Natl Cancer Inst
Главные авторы: Gralow, Julie R, Barlow, William E, Paterson, Alexander H G, M'iao, Jieling L, Lew, Danika L, Stopeck, Alison T, Hayes, Daniel F, Hershman, Dawn L, Schubert, Mark M, Clemons, Mark, Van Poznak, Catherine H, Dees, Elizabeth C, Ingle, James N, Falkson, Carla I, Elias, Anthony D, Messino, Michael J, Margolis, Jeffrey H, Dakhil, Shaker R, Chew, Helen K, Dammann, Kim Z, Abrams, Jeffrey S, Livingston, Robert B, Hortobagyi, Gabriel N
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357327/
https://ncbi.nlm.nih.gov/pubmed/31693129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz215
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы